Von Liebig Forum: Alfred Mann


This installment of the “Profiles in Innovation” series features Alfred Mann, the Chairman of the Board and CEO of MannKind Corporation, a diversified biopharmaceutical company that develops novel therapeutics for diabetes, cancer autoimmune and inflammatory diseases. Series: “Von Liebig Forum” [12/2005] [Public Affairs] [Science] [Show ID: 11117]

Tags: , , ,

This entry was posted on Wednesday, September 8th, 2010 at 4:01 am and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

         Small business phone system for only $20 per user Openings at $75K to $500K+
Business Solutions           Employee Time Clock           Business Coach           Miami Roofer           HP Support           IP Address Lookup           Coralgables Roofing Company           Speed Test           PMP Training           Body Bands           Pinecrest Roofing Company          Get Life Insurance          Miami Metal Roofer         



Leave a Reply